Time points with corresponding measurements
Time point | Measurements |
Tx (during GP recruitment) | 1. GP characteristics:
|
Tx (during GP recruitment) | 2. GP characteristics:
|
T0 (immediately after the initial consultation) | 1. Patient characteristics:
2. BSH treatment (name, defined daily dose, since when)
3. SIS 4. TMT-A 5. DIA-S 6. ISI 7. GAD-7 8. EQ-5D-5L |
Between T0 and T1 (to be documented immediately and summarised at T1) | 1. Falls
2. Other events
|
T1 (6 months after the patient’s initial consultation) | 1. Current BSH intake (name, defined daily dose)
2. No or reduced current BSH intake compared with T0
3. SIS 4.TMT-A 5. DIA-S 6. ISI 7. GAD-7 8. EQ-5D-5L 9. Follow-up phone calls with patients to evaluate the implementation issues and asses any clinical events |
T2 (14 months after the initial consultation of a GP’s first patient) | 1. Qualitative measurements (questionnaires) among GPs in the intervention group:
2. Implementation measurements: GP questionnaires/no of dropouts at different time points of the study (see figure 1) and other issues according to the RE-AIM framework (see chapter 3) |
ATC, Anatomical Therapeutic Chemical; BSH, benzodiazepine/other sedative-hypnotic; DDD, Defined Daily Dose; DIAS, Depression in Old Age Scale; ED, emergency department; EQ-5D, European Quality of Life 5 Dimensions; GAD-7, General Anxiety Disorder-7; GDS-15, Geriatric Depression Scale, 15 item short form; GP, general practitioner; ISI, Insomnia Severity Index; RE-AIM, Reach, Effectiveness, Adoption, Implementation, Maintenance; SIS, Six-Item Screene; TMT-A, Trail-Making Test A.